Literature DB >> 7208144

The ontogeny of thymidine kinase in tissues of man and rat.

A Herzfeld, S M Raper, I Gore.   

Abstract

Thymidine kinase activities, virtually all soluble in rat lung, liver, and small intestine, decreased abruptly late in gestation or immediately after birth. An injection of thyroxine delayed the fetal but not the neonatal changes in liver activity. An injection of cortisol decreased hepatic and pulmonary thymidine kinase activities in both fetal and neonatal rats but had little effect on the intestinal enzyme. Premature extrauterinization led to an earlier occurrence of the quantitative changes in thymidine kinase activity usually seen at term. Birth-associated changes included a rapid transitory increase in the hepatic enzyme and the virtual loss of intestinal thymidine kinase activity. In human tissues, the soluble thymidine kinase in liver remained high between the 11th and 22nd wk of gestation whereas the particulte enzyme, the predominant form in adult liver, rose in the second half of gestation and reached adult levels at birth. In human lung, the soluble enzyme started to decrease by the 16th gestational wk, whereas the particulate thymidine kinase reached the higher adult levels late in gestation. Thymidine kinase in adult human tissues was predominantly particulate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7208144     DOI: 10.1203/00006450-198012000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  Lactobacilli as effectors of host functions: no influence on the activities of enzymes in enterocytes of mice.

Authors:  D D Whitt; D C Savage
Journal:  Appl Environ Microbiol       Date:  1987-02       Impact factor: 4.792

2.  Stability of enterocytes and certain enzymatic activities in suspensions of cells from the villous tip to the crypt of Lieberkühn of the mouse small intestine.

Authors:  D D Whitt; D C Savage
Journal:  Appl Environ Microbiol       Date:  1988-10       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.